The insurer said that it expects to make "better-than-expected" progress toward the new target and revised it original 1.1 billion euros target for value of new business (VNB).
Additionally, ahead of a two-day investor and analyst conference in New York, Aegon said that it remained confident in its U.S. investment portfolio and reiterated that it had no impairments to its subprime-backed asset portfolio.
